Adjuvant anthracycline therapy as a prognostic factor in metastatic breast cancer

被引：0
作者：
Emilio Alba
Nuria Ribelles
Isabel Sevilla
Antonio Rueda
Lorenzo Alonso
Antonia Marquez
Inmaculada Ruiz
José Miramón
机构：
[1] Hospital Clínico Universitario,Servicio de Oncología
来源：
Breast Cancer Research and Treatment | 2001年 / 66卷
关键词：
adjuvant therapy; anthracyclines; breast cancer; chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background. Prognostic factors in metastatic breast cancer continue to be identified. Previous adjuvant chemotherapy appeared to have poor prognosis in some studies but, despite this, the prior use of anthracyclines in the adjuvant setting has not been clearly established as an adverse prognostic factor once metastatic disease develops.
引用
收藏
页码：33 / 39
页数：6
相关论文
共 179 条
[11]  
Jakesz R(1993)The influence of adjuvant chemotherapy on outcome after relapse for patients with breast cancer Eur J Cancer 29 1511-1518
[12]  
Pirich K(1993)Response to chemotherapy after relapse in patients with or without previous adjuvant chemotherapy for breast cancer Cancer Treat Rev 19 21-30
[13]  
Havelec L(1996)Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxor ubicin and fluoruracil in patients with metastatic breast cancer J Clin Oncol 14 764-773
[14]  
Steger G(1996)Dose response relationship of epirubic in in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group J Clin Oncol 14 1146-1155
[15]  
Schlappack O(1998)Construction and validation of a practical prognostic index for patients with metastatic breast cancer J Clin Oncol 16 2401-2408
[16]  
Kolb R(1981)Management of breast cancer patients failing adjuvant chemotherapy with adryamicin-containing regimens Cancer 47 2798-2802
[17]  
Moser K.(1983)Response to secondary therapy in patients with adenocarcinoma of the breast previously treated with adjuvant chemotherapy Cancer 51 381-384
[18]  
Ahmann FR(1986)Salvage treatment of patients suffering relapse after adjuvant CMF chemotherapy Cancer 58 1411-1417
[19]  
Jones SE(1988)Responses to chemotherapy or chemohormonal therapy in advanced breast cancer patients treated previously with adjuvant chemotherapy Cancer 61 415-419
[20]  
Moon TE(1997)Cyclophosphamide and fluoruracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicin J Clin Oncol 15 1897-1905
12345678910